Patents Examined by Laura Schuberg
-
Patent number: 10913929Abstract: The present disclosure provides methods of generating germ layers from stem cells comprising culturing the stem cells in a culture medium having an osmolality less than 340 mOsm/kg. The present disclosure also includes a method to generate different cell lineages from the germ layers as well as to detect them by immunological methods. The present disclosure further provides methods for the generation, isolation, cultivation and propagation of committed progenitor cells and for the production of differentiated cells from the three germ layers. The present disclosure also provides culture media for use in inducing the three germ layers.Type: GrantFiled: October 13, 2010Date of Patent: February 9, 2021Assignee: STEMCELL TECHNOLOGIES INC.Inventors: Alexandra A. Blak, Sharon A. Louis
-
Patent number: 10900009Abstract: The method comprises an automated removal of cells and/or cell colonies from a cell culture whilst executing a first detection step for selecting cells and/or cell colonies with reference to corporeal and/or physical parameters and detecting position data and storing the detected position data of the selected cells and/or cell colonies in a position database. In order to be able to select special cells and/or cell colonies having special properties from the detected cells and/or cell colonies, at least one second detection step for detecting at least one further parameter of the cells and/or cell colonies is then executed, comparative data from the data of the first and second detection step are created, cells and/or cell colonies are selected with reference to the comparative data and the position data from the position database are transferred to a harvesting unit.Type: GrantFiled: October 10, 2017Date of Patent: January 26, 2021Assignee: ALS AUTOMATED LAB SOLUTIONS GMBHInventors: Rafael Backhaus, Jens Eberhardt, Marco Meinhardt, Gerd Bornmann
-
Patent number: 10883080Abstract: An object of the present invention is to obtain a thicker animal cell composition by a simple and less expensive method. Namely, an object of the present invention is to provide a method for culturing a thicker animal cell composition by eliminating the hypoxia associated with animal cell compositions, a method for producing an animal cell composition containing unicellular algae, and an animal cell composition. The present invention provides a method for culturing an animal cell composition in a culture medium in the presence of unicellular algae and under exposure to light. According to the method of the present invention, oxygen can be continuously supplied in the culture medium, cell damage is alleviated, and a thicker cell composition can be obtained in the absence of a capillary network.Type: GrantFiled: June 24, 2016Date of Patent: January 5, 2021Assignee: TOKYO WOMEN'S MEDICAL UNIVERSITYInventors: Tatsuya Shimizu, Yuji Haraguchi, Yuki Kagawa, Katsuhisa Sakaguchi
-
Patent number: 10806755Abstract: Provided herein is a plasma-supplemented fibrinogen and/or fibrin formulation, method for the preparation and use thereof.Type: GrantFiled: February 25, 2015Date of Patent: October 20, 2020Assignee: Omrix Biopharmaceuticals, Ltd.Inventors: Roberto Meidler, Elena Grimberg, Oleg Belyaev, Yonit Tiberman, Israel Nur, Tamar Auerbach-Nevo
-
Patent number: 10750738Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.Type: GrantFiled: April 8, 2008Date of Patent: August 25, 2020Assignee: TRANSMEDICS, INC.Inventors: Robert Fishman, Robert Havener, Ihab Abdel Fattah, Anas Abdelazim, Scott Newell, Thomas H. Bishop, Tamer Khayal, Stanley Kyi, Ron Taylor, Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed Hassanein
-
Patent number: 10731132Abstract: The invention relates to method for the separation of cord blood endothelial cells from hematopoietic cells in a manner that preserves the hematopoietic cells' repopulating ability and primitivity, without significantly reducing the yield of hematopoietic cells. The said endothelial cells from cord blood have a utility in cell based therapeutics. The system described takes advantage of the endogenous adherence properties of the cells to facilitate the separation and separate storage of the cell types.Type: GrantFiled: March 14, 2014Date of Patent: August 4, 2020Assignee: Amniotics ABInventors: Marcus Kare Torleif Larsson, Andreas Nils Walter Herbst, Niels-bjarne Roland Woods
-
Patent number: 10722540Abstract: A method of processing a lipoaspirate sample includes mechanically processing the lipoaspirate sample to generate nanofat. The nanofat is then input into a microfluidic device comprising a plurality of serially arranged stages comprising one or more microfluidic channels having a plurality of expansion and constriction regions extending along the length of the one or more microfluidic channels, wherein each subsequent stage of the plurality has an increasing number of microfluidic channels of decreasing dimensions. The nanofat is flowed through the plurality of serially arranged stages in a plurality of cycles to generate sheared nanofat. The sheared nanofat is then collected after flowing through the plurality of serially arranged stages. The sheared nanofat may then be injected and/or applied to the subject. In an alternative embodiment, filtered or mechanically processed lipoaspirate may be run through the microfluidic device.Type: GrantFiled: January 31, 2017Date of Patent: July 28, 2020Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Jered Haun, Alan Widgerow, Derek Banyard, Xiaolong Qiu
-
Patent number: 10704026Abstract: Methods are provided for long term culture of mammalian intestinal cells. Cultures are initiated with fragments of mammalian intestinal tissue, which are then maintained embedded in a gel substrate that provides an air-liquid interface. Intestinal epithelium in cultures of the invention can be continuously grown for extended periods of time. Mammalian intestinal cells cultured by the methods of the invention recapitulate features of intestinal growth in vivo.Type: GrantFiled: August 10, 2015Date of Patent: July 7, 2020Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Calvin Jay Kuo, Akifumi Ootani
-
Patent number: 10705090Abstract: The invention relates to a system, comprising: a) a sample processing unit, comprising an input port and an output port coupled to a rotating container having at least one sample chamber, the sample processing unit configured provide a first processing step to a sample or to rotate the container so as to apply a centrifugal force to a sample deposited in the chamber and separate at least a first component and a second component of the deposited sample; and b) a sample separation unit coupled to the output port of the sample processing unit, the cell separation unit comprising separation column holder (42), a pump (64) and a plurality of valves (1-11) configured to at least partially control fluid flow through a fluid circuitry and a separation column (40) positioned in the holder, the separation column configured to separate labeled and unlabeled components of sample flowed through the column.Type: GrantFiled: January 21, 2016Date of Patent: July 7, 2020Assignee: MILTENYI BIOTEC B.V. & CO. KGInventors: Stefan Miltenyi, Winfried Schimmelpfennig, Holger Lantow, Niklas Elmar Neuschafer, Martin Biehl, Eiad Kabaha, Jurgen Schulz
-
Patent number: 10660923Abstract: Provided herein are compositions for improving sinus microbiota and treating sinusitis. Further provided are methods of detecting imbalance in the sinus microbiota that can be indicative of sinusitis, and methods of determining whether an individual has or is at risk of developing sinusitis, e.g., chronic sinusitis.Type: GrantFiled: July 6, 2016Date of Patent: May 26, 2020Assignee: The Regents of the University of CaliforniaInventors: Susan Lynch, Andrew Goldberg, Steve D. Pletcher
-
Patent number: 10656142Abstract: Provided herein are methods and materials for assessing platelet activity and/or the ability of substances (e.g., small molecule compounds and compositions comprising the same) to inhibit or activate platelet activity. For example, this document provides methods and materials that can include (a) applying abnormal flow conditions (e.g., oscillatory shear stress) to a sample of platelets (e.g., a blood sample or platelet-rich plasma sample) to stimulate the platelets, and (b) assessing the activity of the platelets. In some embodiments, the activity of the platelets can be assessed by measuring the amount of superoxide radial or the rate and/or level of platelet aggregation within the sample.Type: GrantFiled: October 20, 2015Date of Patent: May 19, 2020Assignee: Melaleuca, Inc.Inventors: Alexander B. Rabovsky, Bruno Fink
-
Patent number: 10570367Abstract: Provided herein are seed train processes and methods of producing a recombinant protein that include the use of these seed train processes.Type: GrantFiled: June 8, 2015Date of Patent: February 25, 2020Assignee: Genzyme CorporationInventors: Michael Bruninghaus, Konstantin Konstantinov, Benjamin Wright, Weichang Zhou
-
Patent number: 10568942Abstract: 5-D-fructose dehydrogenase, optionally in combination with invertase and/or maltase and/or glucose isomerase, may be used to treat fructose intolerance. Other embodiments are also disclosed.Type: GrantFiled: September 19, 2016Date of Patent: February 25, 2020Assignee: PRO NATURA GESELLSCHAFT FÜR GESUNDE ERNÄHRUNG MBHInventors: Daniel Henry Wyrobnik, Isaac Harry Wyrobnik, Elliad Ronen Silcoff
-
Patent number: 10557124Abstract: The invention disclosed herein generally relates to methods and systems for converting stem cells into specific tissue(s) or organ(s) through directed differentiation. In particular, the invention disclosed herein relates to methods and systems for promoting definitive endoderm formation from pluripotent stem cells. The invention disclosed herein further relates to methods and systems for promoting ventral-anterior foregut spheroid tissue formation, 3-dimensional lung tissue formation, and lung organoid tissue formation produced in vitro from the described methods.Type: GrantFiled: April 21, 2016Date of Patent: February 11, 2020Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Jason Spence, Briana Dye
-
Patent number: 10542743Abstract: The present invention relates to a method of isolating mesenchymal stem cells originated from Wharton's jelly (WJ-MSC) from single donor. The method for isolating and proliferating viable cells from Wharton's jelly wherein the method includes the steps of (a) obtaining umbilical cord tissue comprising of viable cells from Wharton's jelly, (b) isolating the viable cells in a sample collection media, (c) preparing a primary stock culture using the viable cells from step (b), (d) proliferating the primary stock culture from step (c) to obtain sub-cultured stocks, (e) harvesting the viable cells from the sub-cultured stocks from step (d) and (f) cryo-preserving the viable cells from step (e) under cryogenic conditions.Type: GrantFiled: January 4, 2016Date of Patent: January 28, 2020Assignee: HYGIEIA THERAPEUTICS SDN BHDInventors: Vijayendran Govindasamy, Wijenthiran Kunasekaran, Naresh Waran Gnanasegaran
-
Patent number: 10526582Abstract: The present disclosure relates generally to the fields of tissue engineering and regenerative medicine. More particularly, the present disclosure generally relates to systems, methods, compositions and kits to rapidly fabricate functionalized three-dimensional tissues from multiple stacks of cell sheets using enzyme-digestible hydrogel substrates as supports for the cell sheets. Methods to generate the multi-layered cell constructs comprise contacting a cell-sheet on one digestible substrate with another cell-sheet on a different digestible substrate, enzymatically digesting with a first enzyme to remove the first substrate and subsequently adding repeating the steps to add another cell-sheet on same digestible substrate to form a multi-layered cell construct as disclosed herein. Additional aspects relate to using the multi-layered cell constructs for therapeutic use, research and in screening assays.Type: GrantFiled: May 14, 2014Date of Patent: January 7, 2020Assignee: TRUSTEES OF BOSTON UNIVERSITYInventors: Joshua Jaeyun Kim, Joyce Yun-Wei Wong
-
Patent number: 10513684Abstract: A method for fabricating a cellular structure is disclosed. The method includes feeding cell aggregates onto a plurality of thread or needle shaped members in each of a plurality of supports. Each member forms net or mesh shaped spaces in the respective support. The method also includes layering the supports with the cell aggregates fed therein, culturing the cell aggregates to fuse, and removing the plurality of thread or needle shaped members from the fused cellular structure.Type: GrantFiled: March 13, 2018Date of Patent: December 24, 2019Inventor: Jiro Ono
-
Patent number: 10487305Abstract: The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.Type: GrantFiled: April 5, 2013Date of Patent: November 26, 2019Assignees: LONDON HEALTH SCIENCES CENTRE RESEARCH INC., COMPAGNIE GERVAIS DANONEInventors: Jordan Bisanz, Gregor Reid, Marc Monachese, Johan Van Hylckama Vlieg, Tamara Smokvina, Jeremy Burton
-
Patent number: 10426801Abstract: A therapeutic or diagnostic delivery vehicle is provided. The delivery vehicle may include one or more particles, such as microparticles, nanoparticles and stimuli-responsive particles, conjugated to a tropic cell that targets at least one pathological entity or site. In addition, a pharmaceutical composition is provided. The pharmaceutical composition may include, among other things, a particle conjugated to a tropic cell such as those discussed above and at least one diagnostic or therapeutic agent, such as those described herein. In some aspects, the tropic cell may target at least one pathological entity or site. Further, methods for diagnosing, monitoring or treating a pathological condition in a subject are provided. Such methods may include administering a therapeutically effective amount of the pharmaceutical composition to a subject.Type: GrantFiled: April 18, 2014Date of Patent: October 1, 2019Assignee: City of HopeInventors: Karen Aboody, Alexander Annala, Rachael Mooney, Jacob Berlin, Yiming Weng
-
Patent number: 10421955Abstract: A method of culturing cells or tissue comprises: (a) disposing cells or tissue in the cavity of a deformable cell culture container; and (b) applying synchronized chronic electrical stimulation and stretch to the cells or tissue in the deformable culture cell container, wherein the synchronized chronic electrical stimulation is applied in the form of pulses at a frequency of from 0.010-99 Hz and a duration of from 0.4 to 24 ms; and wherein stretch cycles are applied to the cells or tissue at a frequency of from 0.010 to 15 Hz.Type: GrantFiled: March 2, 2017Date of Patent: September 24, 2019Assignee: IONOPTIX LLCInventors: Peter G. W. Lee, Douglas L. Tillotson, Richard T. Udale, Katherine L. Barber